Bruker (BRKR) FY2015 results: revenue $1.6 billion, down 10.2% on the year
Bruker Corp. (BRKR) reported revenue of $1.6 billion for fiscal 2015, the year ended 31 December 2015, down 10.2% on the year before. Net income was $102 million, up 79.2%, and diluted earnings per share $0.60. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2016.
Revenue
$1.6 billion
-10.2% on the year
FY2009FY2015
Operating margin
9.0%
5.8% a year earlier
FY2009FY2015
Net income
$102 million
+79.2% on the year
FY2009FY2015
Diluted EPS
$0.60
+81.8% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
1,624
1,809
1,839
-10.2%
Cost of revenue
915
1,046
1,034
-12.5%
Gross profit
709
763
805
-7.2%
Gross margin
43.6%
42.2%
43.8%
Research and development
146
174
190
-16.4%
Selling, general and administrative
392
451
438
-13.0%
Operating income
146
105
148
+38.2%
Operating margin
9.0%
5.8%
8.1%
Interest expense
13.0
13.3
13.4
-2.3%
Pre-tax income
128
101
125
+26.4%
Income tax
23.1
41.7
42.8
-44.6%
Effective tax rate
18.0%
41.2%
34.3%
Net income
102
56.7
80.1
+79.2%
Net margin
6.3%
3.1%
4.4%
Diluted EPS
$0.60
$0.33
$0.48
+81.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
229
114
145
+100.5%
Capital expenditure
34.2
33.8
50.3
+1.2%
Free cash flow
195
80.5
94.7
+142.2%
Free cash flow margin
12.0%
4.5%
5.1%
Cash from investing
-102
n/a
n/a
Cash from financing
-169
n/a
n/a
Depreciation and amortisation
53.3
59.7
61.3
-10.7%
Share-based compensation
8.0
9.4
6.6
-14.9%
Buybacks
90.0
n/a
n/a
Diluted shares, weighted
169m
170m
168m
-0.2%
Shares outstanding at period end
165m
169m
168m
-1.9%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
726
766
846
-5.2%
Non-controlling interest
6.8
5.8
4.1
+17.2%
Debt
265
355
355
-25.3%
Other liabilities
733
738
783
-0.7%
Total liabilities and equity
1,731
1,865
1,988
-7.2%
Fixed assets
231
250
300
-7.5%
Goodwill
131
128
127
+2.2%
Intangible assets
74.7
83.8
106
-10.9%
Investments
201
178
n/a
+13.0%
Cash and equivalents
267
320
439
-16.4%
Receivables
235
293
308
-20.0%
Inventory
422
477
590
-11.6%
Other assets
170
135
120
+25.4%
Total assets
1,731
1,865
1,988
-7.2%
10-K for the year ended 31 December 2015, filed 29 February 2016: the filing.